PubMed Health⌕ Search

PubMed · 1020249

Survival rate in lung cancer.

Abstract

The authors followed the survival rate in 927 patients with lung cancer treated in the oncological dispensary of the Plovdiv City during 1965--1972. 41.3% of the patients were in stage 1--11, 19.9%--in stage III, 38.8%--in stage iv. Of all the patients 8.2% were operated upon, in 14.7%--radiotherapy was employed, 9.9% of the patients were treated pharmacologically, 67.5% of cases were not treated at all. As a result of all kinds of treatment 21.4% of the patients survived for one year, and 1.1%--for 5 years. It is concluded that the search for new methods of the treatment and early diagnosis of lung cancer is quite essential.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P Mandulova, S Khadzhiev. 1976. Survival rate in lung cancer.. https://pubmed.ncbi.nlm.nih.gov/1020249/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

IGF1, growth pathway polymorphisms and schizophrenia: a pooling study.

It has been hypothesized that insulin-like growth factors (IGFs) and components of the growth-hormone (GH)-IGF axis may underlie reported associations of poor fetal and childhood growth with schizophrenia. We have investigated the association of schizophrenia with 16 SNPs spanning the IGF1 gene with an inter-marker distance of approximately 2-3 kb. We also examined associations with four common functional polymorphisms of genes involved in aspects of the GH-IGF system--the IGF1 receptor (IGF1R), insulin receptor substrate (IRS1), growth hormone (GH1), and IGF binding protein-3 (IGFBP3). The study was based on an analysis of pooled DNA samples from 648 UK and Irish cases of schizophrenia and 712 blood donor controls and of 297 Bulgarian parent offspring trios. In replicated pool analyses, none of the 16 SNPs in IGF1 nor the 4 key SNPs in the other growth pathway genes were associated with schizophrenia. SNP coverage of IGF1 was extensive, so our findings do not support a major role for IGF-I in the aetiology of schizophrenia.

Bulgaria↗